Full View

Gaps in evidence‐based therapy use in insured patients in the united states with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - Am Heart Assoc
Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …
被引用次数：43 相关文章 Full View

Gaps in evidence-based therapy use in insured patients in the united states with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - research.monash.edu
BACKGROUND: Evidence-based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Gaps in evidence-based therapy use in insured patients in the united states with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

AJ Nelson, M Ardissino… - Journal of the …, 2021 - utsouthwestern.elsevierpure.com
BACKGROUND: Evidence-based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease.

AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - europepmc.org
Background Evidence-based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Evidence-based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …
[HTML] nih.gov

[HTML][HTML] Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

AJ Nelson, M Ardissino, K Haynes… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Background Evidence‐based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …

Gaps in Evidence-Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease

S Shambhu, ZJ Eapen, DK McGuire, A Carnicelli… - 2021 - Am Heart Assoc
BACKGROUND: Evidence-based therapies are generally underused for cardiovascular risk
reduction; however, less is known about contemporary patients with type 2 diabetes mellitus …